Related references
Note: Only part of the references are listed.Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes
H. Breivik et al.
ANNALS OF ONCOLOGY (2009)
Formulation Selection and Pharmacokinetic Comparison of Fentanyl Buccal Soluble Film with Oral Transmucosal Fentanyl Citrate A Randomized, Open-Label, Single-Dose, Crossover Study
Niraj Vasisht et al.
CLINICAL DRUG INVESTIGATION (2009)
Mechanisms of placebo and placebo-related effects across diseases
Fabrizio Benedetti
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Management of breakthrough pain in patients with cancer
Leeroy William et al.
DRUGS (2008)
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer
Russell K. Portenoy et al.
CLINICAL JOURNAL OF PAIN (2006)
Mechanisms of the placebo response and their impact on clinical trials and clinical practice
DG Finniss et al.
PAIN (2005)
Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey
A Caraceni et al.
PALLIATIVE MEDICINE (2004)
Oral mucosal drug delivery - Clinical pharmacokinetics and therapeutic applications
H Zhang et al.
CLINICAL PHARMACOKINETICS (2002)
Breakthrough cancer pain:: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®)
PH Coluzzi et al.
PAIN (2001)
Share Paper
